GlassScriptPhysician profile
Sander J Leiman
NPI 1457387680
$5,343.24
in general payments reported to CMS, 2019-2025
45 companies · $936 in 2025
The $936 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $535 · 2021: $798 · 2022: $933 · 2023: $538 · 2024: $1,192 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.67 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $592.48 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $539.71 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Pfizer INC. | $372.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $360.93 | 2020-2025 | Farxiga |
| Medtronic, INC. | $326.25 | 2023-2024 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Amgen INC. | $308.21 | 2020-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.67 | 2019-2025 | Jardiance, Tradjenta |
| Janssen Pharmaceuticals, INC | $255.31 | 2019-2022 | |
| Amarin Pharma, INC. | $244.11 | 2019-2022 | |
| Medtronic Vascular, INC. | $183.79 | 2019-2020 | |
| Lilly USA, LLC | $160.89 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Alnylam Pharmaceuticals INC. | $156.90 | 2022-2025 | Amvuttra |
| Boston Scientific Corporation | $140.92 | 2019-2022 | |
| Abbott Laboratories | $139.08 | 2019-2024 | Jot Dx, Mitraclip, Navitor |
| Novo Nordisk INC | $111.72 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $100.47 | 2021-2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $97.38 | 2023-2024 | Sapien 3 Ultra Resilia |
| Tactile Systems Technology INC | $71.21 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kiniksa Pharmaceuticals International, Plc | $69.92 | 2024 | Arcalyst |
| Insulet Corporation | $69.22 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.53 | 2021-2025 | |
| Inspire Medical Systems, INC. | $63.57 | 2025 | Inspire |
| Exact Sciences Corporation | $56.57 | 2023-2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $49.84 | 2022 | |
| Medicomp INC | $47.46 | 2024-2025 | Telepatch Cardiac Monitor |
| Daiichi Sankyo INC. | $45.63 | 2021-2024 | Injectafer |
| Philips North America LLC | $40.73 | 2025 | Mcot |
| Amryt Pharma Holdings LTD | $39.38 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $34.55 | 2021-2022 | |
| Esperion Therapeutics, INC. | $32.44 | 2021-2024 | Nexletol |
| Recordati_rare_diseases_inc. | $30.01 | 2025 | Isturisa |
| Glaxosmithkline, LLC. | $29.41 | 2021-2025 | Shingrix, Arexvy |
| Baxter Healthcare | $26.13 | 2024 | Hillrom - Connex Spot Monitor |
| Renalytix Ai, INC. | $24.61 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Kowa Pharmaceuticals America, INC. | $24.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.69 | 2019 | |
| Bridgebio Pharma, INC. | $21.64 | 2025 | Attruby |
| Lundbeck LLC | $20.63 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $20.22 | 2021 | |
| Eisai INC. | $19.23 | 2025 | |
| Preventice Services, LLC | $15.59 | 2019 | |
| Beta Bionics, INC. | $15.57 | 2023 | Ilet Bionic Pancreas |
| Mannkind Corporation | $13.51 | 2022 | |
| Spinal Elements, INC. | $12.83 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $10.37 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sander Leiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.